Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Venture Life Group Plc LSE:VLG London Ordinary Share GB00BFPM8908 ORD 0.3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 85.50 85.00 86.00 85.50 85.50 85.50 19,466 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 30.1 3.3 2.7 31.2 108

Venture Life Group PLC PDMR Dealings and Issue of Equity

24/11/2020 7:00am

UK Regulatory (RNS & others)


Venture Life (LSE:VLG)
Historical Stock Chart


From Nov 2020 to May 2021

Click Here for more Venture Life Charts.

TIDMVLG

RNS Number : 2484G

Venture Life Group PLC

24 November 2020

24 November 2020

Venture Life Group plc

("Venture Life" or the "Company")

PDMR Dealings and Issue of Equity

Further to the announcement made on 20 November 2020 and as outlined in the Company's circular of the same date the Company notifies the following PDMR dealings.

-- On 20 November 2020, Jerry Randall, Sharon Daly and Gianluca Braguti and certain of his associates conditionally agreed to sell 2,752,751 Ordinary Shares (including Ordinary Shares arising on exercise of EMI Options as outlined below), 1,877,863 Ordinary Shares (also including Ordinary Shares arising on exercise of EMI Options as outlined below) and 3,542,729 Ordinary Shares in the Company, respectively.

-- On 23 November 2020, Jerry Randall, CEO, and Sharon Daly, CCO, have conditionally exercised a total of 1,735,774 EMI Options. Of these EMI Options, 1,411,400 have been exercised at a price per Ordinary Share of 45 pence and 324,374 have been exercised at a price per Ordinary Share of 41 pence.

Both the issue of options and the sale of shares are conditional upon the fundraising, announced at 13:00 on 20 November 2020 (RNS No.0547G) being approved at a General Meeting of Shareholders to be held on 8 December 2020 and the Placing Shares and Open Offer Shares being admitted to trading on AIM on 9 December 2020.

If the resolutions that are to be put to Shareholders are passed at the General Meeting, an application will be made to the London Stock Exchange for the 1,735,774 new Ordinary Shares resulting from the option exercise as well as the Placing Shares and Open Offer Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and trading will commence at 8.00 a.m. on 9 December 2020. The Company will make a further announcement in this regard once the conditions have been met.

Capitalised terms used, but not defined, in this announcement have the same meaning as set out in the Circular.

For further information, please contact:

   Venture Life Group PLC     +44 (0) 1344 578004 

Jerry Randall, Chief Executive Officer

Andrew Waters, Chief Financial Officer

   Cenkos Securities plc (Nomad and Joint Broker)     +44 (0) 20 7397 8900 

Stephen Keys / Camilla Hume/ Cameron MacRitchie (Corporate Finance)

Russell Kerr / Michael Johnson (Sales)

N+1 Singer (Joint Broker)

   Shaun Dobson / Carlo Spingardi (Corporate Finance)      +44 (0) 20 7496 3000 

Jonathan Dighe (Sales)

About Venture Life ( www.venture-life.com )

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 
  1   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                                  1. Jerry Randall 
     -------------------------  ---------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                       1. Chief Executive Officer 
     -------------------------  ---------------------------------------- 
 b)   Initial notification       Initial Notification 
       /Amendment 
     -------------------------  ---------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                       Venture Life Group plc 
     -------------------------  ---------------------------------------- 
 b)   LEI                        213800S8CZUPLAB2KC70 
     -------------------------  ---------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description                Ordinary Shares of 0.3p each in 
       of the financial           Venture Life Group plc 
       instrument, 
       type of instrument 
     -------------------------  ---------------------------------------- 
 b)   Identification             GB00BFPM8908 
       code 
     -------------------------  ---------------------------------------- 
 c)   Nature of the              Conditional Exercise of EMI Share 
       transaction                Options and conditional Sales of 
                                  Shares 
     -------------------------  ---------------------------------------- 
 d)   Price and volumes          Shares 
                                  2,752,751 shares (including Ordinary 
                                  Shares arising on exercise of EMI 
                                  Options as detailed below) to be 
                                  sold at a price of GBP0.90 per 
                                  Ordinary Share 
                                  Options 
                                  705,700 options have been exercised 
                                  at a price of GBP0.45 per Ordinary 
                                  Share and 162,187 options have 
                                  been exercised at a price of GBP0.41 
                                  per Ordinary Share. 
     -------------------------  ---------------------------------------- 
 e)   Aggregated information      See above 
       - Aggregated 
       volume 
       - Price 
     -------------------------  ---------------------------------------- 
 f)   Date of the                20 November 2020 for the sale of 
       transaction                shares (including Ordinary shares 
                                  arising on exercise of options) 
                                  23 November for the exercise of 
                                  options 
     -------------------------  ---------------------------------------- 
 g)   Place of the               London Stock Exchange 
       transaction 
     -------------------------  ---------------------------------------- 
 
 
  1   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                                2. Sharon Daly 
     -----------------------  ------------------------------------------- 
 2    Reason for the notification 
     -------------------------------------------------------------------- 
 a)   Position/status                     2. Chief Commercial Officer 
     -----------------------  ------------------------------------------- 
 b)   Initial notification     Initial Notification 
       /Amendment 
     -----------------------  ------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     -------------------------------------------------------------------- 
 a)   Name                     Venture Life Group plc 
     -----------------------  ------------------------------------------- 
 b)   LEI                      213800S8CZUPLAB2KC70 
     -----------------------  ------------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     -------------------------------------------------------------------- 
 a)   Description              Ordinary Shares of 0.3p each in Venture 
       of the financial         Life Group plc 
       instrument, 
       type of instrument 
     -----------------------  ------------------------------------------- 
 b)   Identification           GB00BFPM8908 
       code 
     -----------------------  ------------------------------------------- 
 c)   Nature of the            Conditional Exercise of EMI Share Options 
       transaction              and conditional Sales of Shares 
     -----------------------  ------------------------------------------- 
 d)   Price and volumes        Shares 
                                1,877,864 shares to be sold to be sold 
                                at a price of GBP0.90 per Ordinary Share 
                                (including Ordinary Shares arising on 
                                exercise of EMI Options as below) 
                                Options 
                                705,700 options have been exercised at 
                                a price of GBP0.45 per Ordinary Share 
                                and 162,187 options have been exercised 
                                at a price of GBP0.41 per Ordinary Share. 
     -----------------------  ------------------------------------------- 
 e)   Aggregated information    See above 
       - Aggregated 
       volume 
       - Price 
     -----------------------  ------------------------------------------- 
 f)   Date of the              20 November 2020 for the sale of shares 
       transaction              (including Ordinary shares arising on 
                                exercise of options) 
                                23 November for the exercise of options 
     -----------------------  ------------------------------------------- 
 g)   Place of the             London Stock Exchange 
       transaction 
     -----------------------  ------------------------------------------- 
 
 
  1   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                            3. Gianluca Braguti and certain 
                                       of his associates 
     -------------------------  ---------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                 3. Chief Manufacturing Officer 
     -------------------------  ---------------------------------------- 
 b)   Initial notification       Initial Notification 
       /Amendment 
     -------------------------  ---------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                       Venture Life Group plc 
     -------------------------  ---------------------------------------- 
 b)   LEI                        213800S8CZUPLAB2KC70 
     -------------------------  ---------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description                Ordinary Shares of 0.3p each in 
       of the financial           Venture Life Group plc 
       instrument, 
       type of instrument 
     -------------------------  ---------------------------------------- 
 b)   Identification             GB00BFPM8908 
       code 
     -------------------------  ---------------------------------------- 
 c)   Nature of the              Conditional Sales of Shares 
       transaction 
     -------------------------  ---------------------------------------- 
 d)   Price and volumes          Shares 
                                  3,542,729 shares to be sold will 
                                  be sold at a price of GBP0.90 per 
                                  Ordinary Share 
     -------------------------  ---------------------------------------- 
 e)   Aggregated information      See above 
       - Aggregated 
       volume 
       - Price 
     -------------------------  ---------------------------------------- 
 f)   Date of the                20 November 2020 
       transaction 
     -------------------------  ---------------------------------------- 
 g)   Place of the               London Stock Exchange 
       transaction 
     -------------------------  ---------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUOVARRAUAUUA

(END) Dow Jones Newswires

November 24, 2020 02:00 ET (07:00 GMT)

1 Year Venture Life Chart

1 Year Venture Life Chart

1 Month Venture Life Chart

1 Month Venture Life Chart
ADVFN Advertorial
Your Recent History
LSE
VLG
Venture Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210510 09:17:40